RxDoctor Payments DataLook up a doctor →

Brittany Hicks, NP

Nurse Practitioner · Gulfport, MSNPI 1538431002

Payments from drug & device makers

$13,641in general payments, 2019–2025

Across 717 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Exelixis Inc.$1K
  • Johnson & Johnson$1K
  • Merck$998
  • AstraZeneca$751
  • Eisai Inc.$751
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$13,24297%
  • Education$3993%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis109$1,630
Exelixis Inc.63$1,307
Johnson & Johnson(2 entities)62$1,038
Merck50$998
AstraZeneca(2 entities)40$751
Eisai Inc.45$751
Lilly USA, LLC29$561
Incyte Corporation25$530
Bristol Myers Squibb20$467
Pfizer27$443
Daiichi Sankyo Inc.17$324
GSK15$309
Beigene USA, Inc.14$280
E.r. Squibb & Sons, L.L.C.11$277
Takeda Pharmaceuticals U.S.A., Inc.11$261
Ipsen Biopharmaceuticals, Inc11$233
Amgen13$209
Astellas Pharma US Inc10$183
Bayer9$166
Gilead7$166
Pharmaessentia USA Corporation6$164
TG Therapeutics, Inc.2$163
Sanofi8$160
Taiho Oncology, Inc.7$134
Adaptive Biotechnologies Corporation5$125
Pharmacyclics LLC, An Abbvie Company6$123
Regeneron Healthcare Solutions, Inc.7$119
Genentech USA, Inc.6$115
Sanofi-aventis U.S. LLC1$100
EMD Serono, Inc.6$97
Coherus Oncology, Inc.5$89
Array Biopharma Inc4$80
Stemline Therapeutics Inc.4$80
Beone Medicines USA, Inc.4$78
Rigel Pharmaceuticals, Inc.4$74
Genmab U.S., Inc.4$68
Caris MPI, Inc.4$67
Sobi, Inc3$60
Boehringer Ingelheim2$55
Sanofi US Services Inc.1$54
Emmaus Medical, Inc.3$50
Tersera Therapeutics LLC2$50
Karyopharm Therapeutics Inc.3$48
Seagen Inc.3$47
Boston Scientific2$46
Geron Corporation2$46
AbbVie2$42
Morphosys, US Inc.2$40
Azurity Pharmaceuticals, Inc.2$36
Jazz Pharmaceuticals Inc.1$34
Pharmacosmos Therapeutics Inc.2$34
AVEO Pharmaceuticals, Inc.2$34
G1 Therapeutics, Inc.2$29
Servier Pharmaceuticals LLC1$24
Sun Pharmaceutical Industries Inc.1$24
Mirati Therapeutics, Inc.1$20
Apellis Pharmaceuticals, Inc.1$19
Immunocore Limited1$18
Sumitomo Pharma America, Inc.1$18
Myovant Sciences Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,641 in reported general payments places this provider in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$883
Medicare patients
13
Services billed
19

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CabometyxCabozantinib S-Malate13$297,736
PromactaEltrombopag Olamine11$249,958
ImbruvicaIbrutinib15$230,216
XtandiEnzalutamide14$201,930
BalversaErdafitinib12$58,966
XareltoRivaroxaban30$24,412
EliquisApixaban23$21,884
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$14,520
Colestipol Hcl18$2,499
Sucralfate11$2,282
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen64$2,052
Letrozole119$1,924
SynthroidLevothyroxine Sodium13$1,773
Fentanyl17$1,692
Anastrozole84$1,179

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Exelixis Inc.Cabometyx$1,307$297,73613 claims
NovartisPromacta$1,630$249,95811 claims
Pharmacyclics LLC, An Abbvie CompanyImbruvica$123$230,21615 claims
Astellas Pharma US IncXtandi$183$201,93014 claims
Johnson & JohnsonBalversa, Xarelto$1,038$83,37842 claims
PfizerEliquis$443$21,88423 claims
GSKTrelegy Ellipta$309$14,52023 claims
AbbVieSynthroid$42$1,77313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →